Background Within the framework of the multi-centre AIRGENE project we studied the association of the Mediterranean diet on plasma levels of various inflammatory markers, in myocardial infarction (MI) survivors from six geographic areas in Europe.
Introduction
An extensive body of scientific evidence shows that there is an association between diet and the incidence of various types of cardiovascular diseases. [1] [2] [3] [4] Dietary factors exert their influence, mainly through their effects on blood pressure, lipids and lipoproteins. 2, 3 Specifically, there is increasing evidence that diets high in fruits, vegetables, pulses and whole grains, and diets including fish, nuts and low-fat dairy products, have favourable health effects and protect from the development and progression of atherosclerosis. 3 The traditional Mediterranean diet, whose principal source of fat is olive oil, encompasses these dietary characteristics. Since the early 1970s, many investigators have recognized the beneficial role of this diet in cardiovascular diseases, [1] [2] [3] [4] [5] metabolic disorders and several types of cancer. 2, 3, 5, 6 The WHO 7 reports that the three major modifiable components involved in preventing atherosclerotic disease are smoking, physical inactivity and unhealthy diet. Recently, Trichopoulou et al. 8 reported reduced overall and coronary heart disease (CHD) mortality based on data from a large scale, multi-centre epidemiological study (i.e. the EPIC). However, although the above evidence is strong and generally accepted, the underlying mechanisms by which the Mediterranean diet may reduce (CHD) mortality and morbidity are not fully understood due to the large number of its potential key elements.
Low-grade systemic inflammation seems to be involved in developing of obesity, insulin resistance and CHD. [9] [10] [11] [12] This implies that measures designed to reduce the inflammatory process could be of benefit in reducing the risk of cardiovascular disease. Since the Mediterranean diet has been suggested as protective against the development and progression of cardiovascular disease [2] [3] [4] [5] [6] [7] [8] 13, 14 it might be reasonable to hypothesize that the benefits from the Mediterranean diet on CHD may, at least in part, be due to various anti-inflammatory mechanisms. Studies reporting on associations between diet and inflammation are few and concern specific groups of population. Thus, Chrysohoou et al. 15 studied a sample of %3000 apparently healthy individuals living in the greater Athens area, Greece, and showed that greater adherence to the Mediterranean diet was associated with lower levels of various inflammatory markers. Similar findings were observed by Esposito et al. 16 in a randomized, single-blind trial conducted in a hospital in Naples, Italy, among 180 patients with the metabolic syndrome. In another randomized clinical trial of dyslipidemic patients in Greece, Paschos et al. 17 observed a reduction in the levels of some inflammatory markers in the Mediterranean diet group. More recently Dai et al., 18 in a twin-study of 345 middle-aged males in the USA, found that adherence to the Mediterranean diet was associated with reduced levels of interleukin-6, but not C-reactive protein. The PREDIMED investigators 19 recently reported that consumption of some typical Mediterranean foods, like fruits, cereals, virgin olive oil and nuts, were associated with lower serum concentrations of inflammatory markers in subjects with high cardiovascular risk living in Spain. However, to our knowledge, the effect of the Mediterranean dietary pattern on inflammatory response among people who already had an acute cardiac event has never been investigated at population level in a multi-centre and multi-cultural study. If adherence to this dietary pattern is shown to have an anti-inflammatory effect, this will bear implications for secondary prevention.
In this work, within the framework of the AIRGENE project, myocardial infarction (MI) survivors from various parts of Europe were examined to evaluate the benefits of a Mediterranean diet on low-grade systemic inflammation
Methods

Patients
A multi-centre longitudinal study in MI survivors was performed in six European cities: Athens (Greece), Augsburg (Germany), Barcelona (Spain), Helsinki (Finland), Rome (Italy) and Stockholm (Sweden), which were chosen to include a variety of geographical conditions. At each location, it was planned to recruit 200 post-MI patients resulting in a study population of 1200 MI survivors. For each subject six repeated clinical examinations were scheduled every 4 weeks. Candidates for the study were identified in population registries 18 of patients with a MI (Augsburg, Barcelona, Stockholm) or in administrative databases of hospital admissions (Athens, Helsinki, Rome). They were contacted either directly or through their hospitals, depending on the national requirements.
MI was defined based on the recommendation of the European Society of Cardiology/American College of Cardiology Committee. 19 Inclusion criteria were: (i) having survived an MI between 3 months and 6 years prior to the start of the study, corresponding to the MI having occurred between 1997 and 2003; and (ii) to be aged between 35 and 80 years. Exclusion criteria were: (i) MI and/or interventional procedures (balloon-dilatation, bypass surgery) <3 months before the beginning of the study; (ii) being no resident of the study area; (iii) an extended period of absence from the study area planned during the study period; (iv) any major illness preventing patients from complying with the study protocol; (v) chronic inflammatory diseases (e.g. Crohn's disease) and anti-coagulation medication intake; and (vi) only one or no valid blood sample available. Samples of patients indicating a cold or the flu, urinary tract infection, gastrointestinal infection, respiratory infection, a surgery or a severe dental intervention during 3 days preceding the clinical visit were excluded. Thus, the studied sample included 1003 MI survivors, fulfilling the inclusion and exclusion criteria and having at least two valid, repeated blood samples taken (Table 1 ). These were 83% of the targeted 1200 patients. Ninety-seven patients had to be excluded because their MI had occurred 46 years ago or not more than one valid blood sample was available. Based on the questionnaire data retrieved during the clinical visits, we excluded 255 of 6068 collected blood samples due to these reasons. Overall, 5813 plasma samples for inflammatory marker determination are available, constituting 97% of the scheduled six blood samples within the 1003 patients. The average number of repeated visits per study subject ranged from 4.5 in Athens to 6.6 in Barcelona. The study period from 9 to 11 months started in May 2003 and ended in July 2004 for all study centres. All partners had the study protocol approved of at their local ethical committees. Informed consent was obtained from all patients at the first clinical visit after a detailed description of the study protocol.
Outcome, exposure and confounders assessment The health status of every patient including a history of CHD and other co-morbidities was assessed at the first visit at the local study centre. The baseline questionnaire assessed regular exercise, smoking history, environmental tobacco exposures, socioeconomic status, dietary habits and alcohol intake. Medication intake was recorded including brand name, dose and intake pattern. Clinical measurements included blood pressure measurement, determination of the body mass index (BMI), and a 12-lead ECG recording. Plasma samples were collected and high sensitivity C-reactive protein (CRP; mg/l), fibrinogen (g/l) and interleukin (IL)-6 (pg/ml) concentrations were measured at all centres at each visit. Individual clinical visits were to be scheduled on the same day and at the same time of the week to minimize the impact of circadian variation and the impact of the week day. If patients suffered from acute infections, such as a cold or influenza, examinations were postponed. At every clinical visit, an EDTA-plasma sample was collected for inflammatory marker determination and a short questionnaire was administered recording information on time-varying individual risk factors such as smoking or dietary intake of antiinflammatory food. A 7-day recall on medication intake was obtained. Venous blood samples were taken in EDTA tubes according to standardized procedures. Plasma aliquots were stored at À808C at every study centre until shipped to the central laboratory in Ulm, Germany. The biochemical evaluation was carried out in that laboratory following the criteria of the World Health Organization Reference Laboratories. For Athens, no fibrinogen data were available as the samples taken did not pass the internal quality assurance tests for fibrinogen determination. More details on exposure assessment may be found in Peters et al. 20 The evaluation of nutritional habits was based on a semi-quantitative food-frequency questionnaire (FFQ). We asked all patients to report their daily or weekly average consumption of 14 food items during the last year, using eight pre-coded levels: never or less than once per month; 1-3 times per month; once per week; 2-4 times per week; 5-6 times per week; once per day; 2-3 times per day; 4 times or more per day. The frequency of consumption of different food items was quantified approximately in terms of the number of times per month the food was consumed (range from 0 for 'never' to 122 for '4 times or more per day'). Consumption of citrus fruits and berries, other fruits and fruit juices, green leafy and cabbage like vegetables and other vegetables, consumption of blue fish and other fish, consumption of pulses and nuts were grouped together, thus the food items were reduced to nine. According to the monthly frequency each food item was consumed, we formed three groups based on the distribution of each item. In detail, those consuming less than the 25th percentile of the marginal distribution were assigned to 'lower' consumption category, those consuming between the 25th and 75th percentile to 'medium', and those consuming above the 75th percentile were assigned to the 'high' consumption category. We then assigned value of three to the most health protective dietary category (referring to the recommended Mediterranean diet 7, 8 ) of consuming items of each food category, value of two to the middle category and value of one to the most 'unhealthy' consumption pattern. These values are shown in Table 2 . We then added the score of each individual to all nine food groups and thus obtained a 'diet score' (ranging between 13 and 23) where a higher value in this score indicates greater adherence to a Mediterranean diet. Furthermore, since current data suggest that alcohol seems to have specific cardioprotective actions, 5 we evaluated separately the effect of alcohol consumption on inflammation. We categorized alcohol consumption in three categories: no consumption; moderate (40 g/day, <20 g/day for women or 40 g/day, <40 g/day for men); heavy (520 g/day for women or 540 g/day for men). We also differentiated between the consumption of red wine or beer. We coded red wine in three categories using the 25th and 75th percentiles of the distribution: no consumption; medium consumption (1-12 glasses per month); and high consumption (412 glasses per month). Beer was coded in the same ways: no consumption; medium consumption (1-20 g/ day) and high consumption (420 g/day).
With the baseline evaluation of the patients we also obtained data on sex, smoking history (never, ex or occasional, current smoker), regular exercise (inactive, partly active, irregularly active, regularly active and trained) and BMI (kg/m 2 ). Resting blood pressure (BP) was measured three times in the right arm of every subject in sitting position after the completion of the baseline questionnaire. Patients whose average BP levels were 5140/90 mmHg or who were on antihypertensive medication were classified as having hypertension. Hypercholesterolemia was coded into three categories: normal (<200 mg/dl); intermediate (200-250 mg/dl); high (4250 mg/dl). Diabetes mellitus was defined as a fasting blood glucose 4125 mg/dl or the use of anti-diabetic medication.
Furthermore, we grouped medication in to 21 categories. The decision on which categories to retain in each multivariate model was taken by stepwise regression. The following medications were significantly associated with CRP were: 'statins'; 'medication with impact on inflammation'; 'medication for sensory organs'; 'systemic anti-infectives'; 'systemic analgesics'; 'diuretics'; 'medication for the respiratory system'; 'nitrates' and 'ACE-inhibitors'. The medications significantly associated with IL-6 were: 'medication for the musculoskeletal system'; 'medication with impact on inflammation'; 'medication for obstructive airways'; 'anti-thrombotics'; 'medication for thyroid therapy'; 'nitrates' and 'antipyretics'. The medications significantly associated with fibrinogen were: 'anti-infectives for systemic use'; 'medication for sensory organs'; 'analgesics for systemic use'; 'nitrates'; 'medication for nervous system'; 'diuretics'; 'medication for the respiratory system'; 'expectorants'; 'medication for musculoskeletal system' and 'ACE-inhibitors'. The identified determinants were included as covariates in the models to adjust for potential confounding.
Statistical analysis
Continuous variables are presented as mean AE SD. Categorical variables are presented as absolute and relative frequencies. Spearman rank correlation coefficient was used to evaluate linear relationships between inflammatory marker levels and the diet score. Mixed models were applied in order to evaluate the associations between inflammatory marker levels and adherence to the Mediterranean diet measured by the diet score, after adjusting for various potential confounders. These models take into account both permanent patient characteristics and time varying factors and thus account for the repeated measurements per patient. All reported P-values are based on two-sided hypotheses. Stata 8 software was used for all analyses (Stata Corp, College Station, TX, USA).
Results
In Table 3 , levels of inflammatory markers of the 1003 participants of the AIRGENE study are presented by diet score. In Table 4 the distributions of patients according to the values of various relevant factors is shown in the three levels of adherence to the Mediterranean diet. It appears that smoking and diabetes are associated with a lower adherence to this dietary pattern. However, it should be noted that current smokers were under-represented in some samples (e.g. in the German sample there were no current smokers). Moreover, the distribution of patients on the three dietary groups differed in the various cities. Dietary habits were not associated with age, sex, BMI and physical activity status.
To account for potential confounding effects, we applied multivariate linear mixed effects models with log(CRP) or log(IL-6) or fibrinogen as outcomes, and sex, smoking history, regular exercise, BMI diabetes and medication intake as potential confounders. We observed that CRP and IL-6 levels were inversely associated with the diet score after adjusting for city, sex, age, BMI, smoking habits, physical activity status and medication intake (Tables 5 and 6 ). For each unit of increase in the adherence to the Mediterranean diet score there was a reduction of 0.030 U of log(CRP) (95% CI 0.005-0.055) that is a 3.1% reduction in the average CRP levels (95% CI 0.5-5.7%). The same increase in the diet score was associated with a reduction of 0.019 U of log(IL-6) (95% CI 0.005-0.033) that is a 1.9% reduction in the average IL-6 levels (95% CI 0.5-3.4%). No significant association was observed between diet score and fibrinogen levels ( Table 7) . There was no significant interaction between sex and diet score on log(CRP) and log(IL-6) levels (data not shown). The effects of adherence to a Mediterranean diet on CRP and IL-6 were consistently protective in separate analyses by city with the exception of Augsburg, but did not reach statistical significance in most cities due to the smaller statistical power. We further evaluated the association between alcohol intake and levels of inflammatory markers (Table 8) . We observed that moderate red wine consumption (1-12 wine glasses per month) was inversely associated with log(CRP), log(IL-6) levels and fibrinogen, after adjusting for the diet score and other potential confounders mentioned above. Additionally, heavy red wine consumption and alcohol intake were inversely associated with fibrinogen levels. No significant associations were observed between beer, other alcoholic beverage intake and CRP and IL-6 levels. It should be noted that after having introduced variables representing alcoholic intake into the models, the coefficients of the diet score remained practically identical.
Discussion
We studied the levels of inflammatory markers in relation to dietary habits in post-MI patients from various parts of Europe and found that after having taken into account several potential confounders, higher adherence to the Mediterranean dietary pattern was independently associated with the reduction of CRP and IL-6 levels. Moreover, we observed that moderate red wine intake was also associated with lower levels of the investigated inflammatory markers, irrespective of dietary habits or other potential confounders. Our findings add to the current scientific knowledge about the benefits of this traditional diet on atherosclerotic disease, since they provide further evidence for the aptitude of this dietary pattern to modulate low-grade systemic inflammation in MI survivors. To the best of our knowledge this is the first study to examine the effects of a Mediterranean diet on inflammatory markers in cardiac patients in various countries in Europe. The few previous studies reporting an association between diet and inflammation were limited to population groups in one single country having specific characteristics. [15] [16] [17] [18] [19] During recent years the Mediterranean diet, one of the traditional diets, has received much attention because of its protective role regarding various health outcomes, like the development of cancer or cardiovascular disease. [13] [14] [15] [16] [21] [22] [23] The benefits from this traditional diet on atherosclerosis have been partially explained by the reduction of blood pressure levels, BMI, platelet aggregation and other haemorrheological factors, as well as the modulation of oxidative stress and the inflammatory response. 13, 15, 16, 21 . To the best of our knowledge, the influence of a Mediterranean diet on inflammatory markers levels in 'free-eating' patients who had already had an acute cardiac event has never been investigated. Patients included in the AIRGENE study had inflammatory marker levels which were in the high end of the distribution of inflammatory markers in random samples from the same study areas. 15, [24] [25] [26] Here, we found evidence that post-MI participants who were more adherent to the Mediterranean dietary pattern had lower CRP and IL-6 levels, as compared with those who were less adherent to this dietary pattern.
Low-grade systemic inflammation is considered to be a strong risk factor of atherosclerosis and consequent cardiovascular events. [9] [10] [11] [12] According to our results, adherence to a Mediterranean diet may not only prevent the development of atherosclerosis in the general population, 15 but may be beneficial even in those who have survived an acute MI. To understand the reasons why adherence to this dietary pattern may reduce the levels of inflammatory markers, we have to appraise the components of this dietary pattern. Mediterranean dietary pattern is low in saturated and high in monounsaturated fat, mainly from olive oil, high in complex carbohydrates, from pulses and high in fibre, mostly from vegetables and fruits. Total fat may be high ($40% of total energy intake), but the monounsaturated-to-saturated fat ratio is around two. Frequently consumed foods and dishes also comprise large quantities of bread and pasta, cereals, pulses and vegetables, cooked meals with olive oil, soups and salads with high quantities of in olive oil. 7, 14, 27, 28 Milk intake is rather low, whereas the consumption of low-fat feta cheese and yogurt is high. People prefer fish to meat which guarantees a high intake of essential fatty acids, 11 It has also been suggested that higher concentrations of plasma cytokines, IL-6, fibrinogen and tumour necrosis factor-a, could promote low-grade systemic inflammation in apparently healthy individuals. 11 However, the exact relationship between these pro-inflammatory markers and dietary habits is not clear. Recently, Perez-Himenez summarizing the conclusions of an International Conference on the healthy effects of olive oil reported that inflammation, endothelial function and oxidative stress are positively modulated by the consumption of Mediterranean dietary, and some of these effects have been attributed to the components of virgin olive oil, like oleic acid which is a monounsaturated fatty acid, vitamin E and phenolic compounds. 29 Several investigators have demonstrated that a-linoleic acid supplementation lowers the concentrations of inflammatory markers, 17, [30] [31] [32] [33] which may in part provide a pathway of the effect of Mediterranean diet on inflammation.
Although the association between elevated plasma fibrinogen and coronary risk may also reflect, in part, an ongoing inflammatory process, 34 in this analysis, we did not observe any association between dietary habits and levels of fibrinogen. This appears to be partly consistent with previously reported results. In a recent review paper, de Maat 35 suggests that the effect of dietary components on plasma fibrinogen levels is modest. It should be noted that fibrinogen was assessed in five out of six cities. We observed that moderate (1-12 glasses per month) red wine intake was associated with lower levels of CRP and IL-6 levels, while no association was observed between other alcoholic beverages and levels of these inflammatory markers. Alcoholic beverages (and especially red or white wine) are consumed moderately and almost always during meals in the Mediterranean diet context, and have been proposed as potential mechanisms of the beneficial effect that this dietary pattern has on human health. It has been suggested that dietary polyphenols and specifically grape polyphenols are associated with decreased risk of CHD by improving plasma lipid profiles and reducing inflammation. 36, 37 Moreover, Imhof et al.
38
reported that moderate consumption of either wine or beer was associated with lower levels of systemic inflammatory markers, suggesting that ethanol itself might be largely responsible for the potential antiinflammatory effects of these beverages. However, in an editorial article, de Lorgeril and Salen 37 commented that it is hard to say that alcohol drinking may moderate cardiovascular risk through the inflammation process, since vascular inflammation is a very complex phenomenon involving a number of local and systemic mediators, as well as several circulating and arterial cells. However, not all work reported in the literature shows consistent results. Thus, in a randomized intervention trial in 101 German citizens with established CHD, no benefit of adhering to the Mediterranean diet was observed on lowering inflammatory markers after 1 year of follow up. 39 This evidence should be considered in the context of the short follow up, the small sample size and the special characteristics of the participants in terms of their dietary habits.
This work has several strengths, but also some limitations. The large cohort of post MI patients (about 1000), the six consecutive measurements of inflammatory biomarkers, the various geographic areas represented and the adjustments for confounding made are some of its strengths. The use of many consecutive measurements is a major strength in biological studies. Block et al. 40 reported that the effect of using one single measurement in the study of biomarkers (i.e. CRP levels) could modify the regression coefficient by 40%. The enrolment of post-MI patients extrapolates current scientific knowledge from primary to secondary prevention. Further, the multi-country origin of the population provides more sound evidence than single-centre studies. However, misreporting of food items consumed and especially alcohol consumption, due to social class could be a potential residual confounder. Another limitation is that our dietary questionnaire was applied once, retrieving the last year's nutritional habits. It is conceivable that MI survivors could have modified their diet after the event. It should be noted, however, that in our study all subjects had experienced an MI, thus all were exposed to the same motivation for adjusting their habits. Therefore, their relative ranking with respect to the 'diet score' used here is probably stable. Further, our questionnaire was rather short, had not been formally validated and, although it covered the consumption of the essential food items, it does not allow the calculation of total energy intake or the dietary analysis for nutrient components (including electrolytes). Therefore, the role of fatty acids, polyphenols or other nutrients was not directly evaluated. Finally, the majority of MI patients were treated with lipid lowering agents and other antithrombotic drugs, mainly statins and aspirin, which are associated with reduced inflammation. Detailed adjustment for medication has been performed. Although it may be theoretically possible to have residual confounding, the fact that the model coefficients were practically identical after adjusting for medication use indicates this it is not a confounder because it is independent of the reported dietary habits.
Conclusion
Studying MI survivors from six European countries, the present work suggests that a reduced inflammatory response in post-MI patients may represent an additional pathophysiological mechanism by which the Mediterranean diet is beneficial for human health, and, especially for CHD. Our findings underline the need for dietary interventions, both in healthy as well as in diseased subjects which promote a low intake of animal fat such as in the Mediterranean diet, to reduce the burden of atherosclerotic diseases.
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